Morningside Group
Venture Capital
We invest in a wide range of opportunities.
Seed
Early Stage
Growth
Biotech
Healthcare
Life Sciences
SaaS
Medtech
digital health
life sciences
novel science
- Headquarters
- Hong Kong, Hong Kong
- Founded
- 1987
- Website
- morningside.com
- AUM
- $2.2B
- Portfolio Companies
- 41
- Last Investment
- Feb 2022
- Geographic Focus
- Asia, North America, United States
Investment Thesis
We invest in a wide range of opportunities.
Portfolio41
GB
GreenLight BioV
VigeoF
F-WaveED
Eko DevicesS
SemiosF
F2GPT
Prilenia TherapeuticsB
BiotheaGS
Ground SignalC
CognoaI
InotremM
MeVoxN
Neuroelectrics
CS
Combined SolarN
Neutrolis3T
30 TechnologyD
DeepCureCS
Cairn SurgicalS
SuveraM
MedRhythmsC
CytedM
MedAnnexP
PelicargoE
EndolytixFT
FireCyte TherapeuticsCT
ClearB TherapeuticsC
CellCentricG
GeneoscopyID
Ieso Digital HealthFB
Fount Bio
A
ApnimedV
ValitorAB
Alamar BioA
AdisoA
Adjuvance